A medical technology can be promising without being appropriate for every patient. To assess a claim, identify the exact device, intended use, regulatory status and evidence of benefit.
The FDA’s AI-enabled medical-device resource explains that devices can reach the market through different pathways, including clearance, De Novo classification and approval. Those terms should not be used interchangeably.
What was actually evaluated?
A tool may support a clinician with a defined task rather than diagnose every condition independently. Ask which population was studied, what comparison was used and whether the outcome concerns accuracy, workflow or improved health.
A high score on one test set does not establish equal performance in every clinic. Availability also does not mean the tool is used routinely across the country.
Wearable information has limits
An alert or estimate can prompt a conversation, but it is not automatically a diagnosis. Check the product’s stated purpose and instructions rather than assuming a consumer device provides continuous medical protection.
Discuss concerning symptoms with a qualified professional instead of waiting for an app to confirm them.
Questions worth asking
What decision will the result change? What are the false-positive and false-negative risks? Who receives the data, and what follow-up is available?
The preventive-care guide explains why more testing is not always better. The halted mining-study account distinguishes an unanswered research question from a finding. The protein-guideline guide shows why a population recommendation still needs individual context. Useful innovation coverage examines the actual evidence rather than promising that new technology has replaced clinical judgment.
Leave a Reply